Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef®): Results of a double blind field trial versus chloroquine in Nigeria

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 82, Issue 4, 1988, Pages 524-529

  Kollaritsch, H ^a   Stemberger, H ^a   Mailer, H ^b   Kremsner, P ^a   Kollaritsch, R ^a   Leimer, R ^c   Wiedemann, G ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Dept of Intl Clinical Research   (Austria)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; FANSIMEF; MEFLOQUINE; PYRIMETHAMINE; SULFADOXINE;

ADOLESCENT; ADULT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HEADACHE; HEART PALPITATION; HEARTBURN; HUMAN; INSOMNIA; MALARIA FALCIPARUM; NAUSEA; NIGERIA; PLASMODIUM FALCIPARUM; PROTOZOON; SCHOOL CHILD; SHORT SURVEY; STOMACH PAIN; VERTIGO;

ADOLESCENT; ADULT; ANIMAL; ANTIMALARIALS; ASPARTATE AMINOTRANSFERASES; BLOOD CELL COUNT; CHILD; CHLOROQUINE; CLINICAL TRIALS; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMAN; MALARIA; MALE; MIDDLE AGE; NIGERIA; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; QUINOLINES; RANDOM ALLOCATION; SULFADOXINE; SULFANILAMIDES;

EID: 0023749215     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/0035-9203(88)90492-0     Document Type: Article

References (16)

1. Boudreau, E. F., Webster, H. K., Pavanand, K. & Tsoshinga, L. (1983). Type II mefloquine resistance in Thailand. Lancet, 2, 1335.
2. Bygbjerg, I. C, Schapira, A., Flachs, H., Gomme, G. & Jepsen, S. (1983). Mefloquine resistance of falciparum malaria from Tanzania enhanced by treatment. Lancet, 2, 774-775.
3. Centers for Disease Control (1985). Revised recommendations for preventing malaria in travellers to areas with chloroquine-resistant Plasmodium falciparum. Morbidity and Mortality Weekly Report, 34, 185-190.
4. Fernex, M. & Leimer, R. (1984).Fortschritte in der Chemoprophylaxe und -therapie der Malaria. Schwer-punktmedizm, 7, 44-52.
5. Harinasuta, T., Bunnag, D., Vanijanond, S., Charoenlarp, P., Suntharasmai, P., Chitamas, S., Sheth, U.K. & Werndsdorfer, W. H. (1987). Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for detennining the most effective dose. Bulletin of the World Health Organization, 65, 363-367.
6. Kollaritsch, H. & Kremsner, P. G. (1987). A new preparation in the treatment and prophylaxis of malaria: mefloquine (Lariam®). Wiener Klinische Wochenschrift, 99, 345-351
7. Merkli, B. & Richie, R. (1980). Studies on the resistance to single and combined antimalarials in the Plasmodium berghei mouse model. Acta Tropica, 37, 228-231.
8. Merkli, B. & Richie, R. (1983). Experimentally derived stable mefloquine resistance in Plasmodium yoelii nigerien-sis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 77, 141-142.
9. Merkli, B., Richie, R. & Peters, W. (1980). The inhibitory effect of a drug combination on the development of mefloquine resistance in Plasmodium berghei. Annals of Tropical Medicine and Parasitology, 74, 1-9.
10. Miller, K. D., Lobel, H. O., Satriale, R. F., Kuritsky, I. H., Stern, R. & Campbell, C. C. (1986). Severe cutaneous reactions among American travellers using pyrimethamine-sulfadoxine Fansidar© for malaria prophylaxis. American Journal of Tropical Medicine and Hygiene, 35, 451-458.
11. Mimica, I., Fry, W., Eckert, G. & Schwartz, D. E. (1983). Multiple-dose kinetic study of mefloquine in healthy male volunteers. Chemotherapy, 29, 184-187.
12. Muto, T., Ebisawa, I. & Mitsui, G. (1971). Malaria in Lagos, II. Peripheral leukocyte counts during longterm administration of combined folic inhibitors (pyrimethamine and sulformethoxine or sulformonomethoxine). Japanese Journal of Experimental Medicine, 41, 459-470.
13. Peto, T. E. A., & Gilks, C. F. (1986). Strategies for the prevention of malaria in travellers: comparison of drug regimens by means of risk-benefit analysis. Lancet, 1, 1256-1260.
14. Smrkovski, L. L., Buck, R. L., Alcantara, A. K., Rodrigez, C. S. & Uylanco, C. V. (1982). In vitro mefloquine resistant Plasmodium falciparum from the Philippines. Lancet, 2, 322.
15. Stemberger, H., Leimer, R. & Wiedermann, G. (1984). Tolerability of long-term prophylaxis with Fansidar: a randomized doubleblind study in Nigeria. Acta Tropica, 41, 391-399.
16. Win, Kyaw, Lwin, T. T., Thwe, Y. & Win, Khin (1985). Combination of mefloquine with sulfadoxine-pyrimetha-mine compared with two sulfadoxm-pyrimethamine combinations in malaria chemoprophylaxis. Lancet, 2, 694-695.